Rhinovirus/enterovirus identification by electron microscopy in lower respiratory tract infection in a patient with relapsed myelodysplastic syndrome after allogeneic hematopoietic cell transplantation and donor lymphocyte infusion

Transpl Immunol. 2023 Apr:77:101792. doi: 10.1016/j.trim.2023.101792. Epub 2023 Jan 20.

Abstract

Donor lymphocyte infusion (DLI) is a curable treatment option, inducing a graft-versus-tumor effect in patients with relapsed hematological malignancies after allogeneic hematopoietic cell transplantation (allo-HCT). However, not only graft-versus-host disease but also pulmonary complications are problematic adverse events after DLI. Although viral infections can be associated with pulmonary complications after DLI, the mechanism underlying these complications remains unclear. Detecting the causative virus infections after pulmonary complications following DLI is challenging, as invasive examinations, such as bronchoalveolar lavage and lung biopsies, are necessary. Family Picornaviridae, including Human-Rhinovirus (HRV) and Enterovirus (EnV), can induce fatal lower respiratory tract infection (LRTI) in recipients who undergo allo-HCT, which can be underdiagnosed. We encountered a 62-year-old man with relapsed myelodysplastic syndrome 20 days after a second HLA-haplo-identical allo-HCT and 4 DLI procedures who was later found to have HRV and EnV LRTI by postmortem electron microscopy. Despite high-dose immunosuppression, severe hypoxemia did not improve, and he succumbed to respiratory failure. Immunosuppressive therapy for idiopathic pneumonia syndrome after allo-HCT may be effective, but its efficacy for acute respiratory failure after DLI is controversial. Our case indicated that the control of viral replication should be prioritized over that of inflammation in HRV and EnV LRTI after DLI.

Keywords: Allogeneic hematopoietic cell transplantation; Donor lymphocyte infusion; Electron microscopy; Enterovirus; Rhinovirus.

Publication types

  • Case Reports

MeSH terms

  • Enterovirus*
  • Graft vs Host Disease* / pathology
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Lymphocyte Transfusion / methods
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes* / etiology
  • Myelodysplastic Syndromes* / therapy
  • Neoplasm Recurrence, Local / etiology
  • Respiratory Tract Infections* / etiology
  • Rhinovirus
  • Transplantation, Homologous